The Andrew Sabin Family Foundation Initiative for AI-Driven Cancer Risk Management
A $1.5 million gift from the Andrew Sabin Family Foundation will support MSK researchers using artificial intelligence, genomics, and data science to better understand cancer risk and advance prevention strategies.
Highlights
- A $1.5 million gift from the Andrew Sabin Family Foundation launches a new initiative focused on AI-driven cancer risk management.
- MSK researchers led by Kenneth Offit, MD, MPH, will use artificial intelligence, genomics, and data science to better understand and predict cancer risk.
- The initiative aims to advance prevention and early intervention by uncovering new insights into the factors that contribute to cancer development.
Harnessing the power of AI to unlock new insights into cancer risk
Memorial Sloan Kettering Cancer Center (MSK) is pleased to announce the Andrew Sabin Family Foundation Initiative for AI-Driven Cancer Risk Management.
The Andrew Sabin Family Foundation has long been a committed partner in advancing cancer research and prevention at MSK. This new initiative will support efforts led by Kenneth Offit, MD, MPH, to harness artificial intelligence (AI) and data science to improve how we understand and identify people at increased risk of cancer. Dr. Offit is Director of the Robert and Kate Niehaus Center for Inherited Cancer Genomics, Chief of the Clinical Genetics Service, Vice Chair of Academic Affairs in the Department of Medicine, Co-Leader of Population Sciences Research, and Robert and Kate Niehaus Chair in Inherited Cancer Genomics.
Through this initiative, MSK will expand its work integrating clinical, genetic, and environmental data to better define the factors that contribute to cancer risk. By applying advanced computational approaches to large, complex data sets, investigators aim to predict risk earlier and develop more effective strategies for prevention and early intervention. Their work reflects a growing opportunity to use emerging technologies to refine how cancer risk is understood and managed in clinical care.
The initiative will further support Dr. Offit and his team within the Niehaus Center for Inherited Cancer Genomics as they continue to advance research at the intersection of artificial intelligence, genomics, and cancer prevention. As these tools evolve, they provide new insights into the biological and environmental drivers of cancer risk and help translate them into meaningful strategies for patients.
A $1.5 million gift from the Andrew Sabin Family Foundation will fund this work under Dr. Offit’s leadership, extending the foundation’s long-standing partnership with MSK in advancing cancer prevention.
